Progenics Sends Letter to Shareholders

NEXT STORY
AB Science provides update on masitinib programs timelines
PREV STORY
Sorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Progenics Sends Letter to Shareholders

NEXT STORY
AB Science provides update on masitinib programs timelines
PREV STORY
Sorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sunshine Heart Announces OPTIONS HF Clinical Experience

EDEN PRAIRIE, Minn., May 24, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced ...

author_avatar
NASDAQ Market News

OLYSIO® sales during the first quarter 2016

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the global first ...

author_avatar
NASDAQ Market News

Tesaro Announces Participation at Two Investor Conferences

WALTHAM, Mass., Feb. 02, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News